In contrast, Systemic SP-D has been shown previously to decrease in T2DM, be positively associated with insulin sensitivity [10], and negativity associated with obesity [11, 12]. This evidence concerns the gene SFTPD and obesity due to melanocortin 4 receptor deficiency.